Table 1.
Multicargo chaperone | pI/103 Mw | Known binding interaction(s) with secreted substratesa | Mutant virulence defect | Interaction with conserved T3SS component | Relevant references |
---|---|---|---|---|---|
InvB | 4.5/14.9 | SspA(SipA), SopE/E2, SopA | Yes | 6, 19, 20, 43 | |
Spa15 | 4.3/15.2 | IpaA, IpgB1, IpgB2, OspB, OspC1, OspC2, OspC3, OspD1, OspD2 | NDb | 60, 61, 67 | |
CesT | 4.4/17.7 | Tir, Map, EspF, EspG, EspH, EspZ, NleA, NleG, NleH, NleH2 | Yes | EscN | 1, 16, 23, 73 |
HpaB (162 aa) | 4.3/18.5 | AvrBs1, AvrBs3, XopF1 | Yes | HrcN, HrcU, HrcV | 3, 7, 8, 46 |
Mcsc | 4.6/18.8 | Ct618, Cap1, Ct225 | ND | CdsQ | 68 |
SrcA | 4.6/16.1 | SseL | Yes | SsaN | 11 |
Listed by direct interactions in experimental binding assays. Additional roles in effector secretion without demonstrated binding have been observed in some cases.
ND, not determined.